Lumida
/PSTX
⌘K
Poseida Therapeutics Inc

Poseida Therapeutics Inc

PSTX
$9.50USD-0.63%-0.06 today

MARKET CAP

925.9M

P/E (TTM)

FWD P/E

DAY RANGE

$9 – $10

52W RANGE

$2
$10
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023TREND
Sales, Adj.$31.2M$130.5M$64.7M
YoY %+317.7%-50.4%
P / Sales
EV / Sales
Gross Profit, Adj.$31.2M$130.5M$64.7M
YoY %+317.7%-50.4%
Margin %100.0%100.0%100.0%
EV / Gross Profit
EBITDA, Adj.$-136.9M$-54.8M$-123.9M
YoY %-10.4%+60.0%-126.2%
Margin %-438.1%-42.0%-191.5%
EV / EBITDA
EBIT$-141.4M$-59.9M$-129.5M
YoY %-11.7%+57.6%-116.0%
Margin %-452.7%-45.9%-200.2%
EV / EBIT
Net Income$-125.0M$-64.0M$-123.4M
YoY %+3.7%+48.8%-92.9%
Net Margin-400.1%-49.0%-190.8%
EPS (GAAP)-$2.01-$0.89-$1.37
YoY %+44.3%+55.7%-53.9%